• ქართული
  • English
  • Allergan moves in as Shire rebuffs $63 billion Takeda bid: sources

    NEW YORK/LONDON (Reuters) – Drugmaker Shire has rejected a third takeover bid worth nearly $63 billion from Japan’s Takeda Pharmaceutical , although talks are continuing, while sources said Allergan was also in competing negotiations.

    Market Quotes by TradingView